MENU
QNCX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Quince Therapeutics (QNCX) Ownership - Who owns Quince Therapeutics?
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
32
Web
https://www.quincetx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
78.21M
P/E Ratio
N/A
Total Cash
31.6M
Projected Growth
N/A
Total Debt
15.75M
Revenue
N/A
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash/Share
0.61
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
QNCX
Capitalization
78.2M
P/E Ratio
N/A
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash
31.6M
Total Cash/Share
0.61
Total Debt
15.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
18.6M
P/B Ratio
4.21
Cash Flow
N/A
Earnings
-1.39
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
44K
Current Ratio
4.05
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-40.25M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-45.58
Shares Held By Institutions
10M
Shares Outstanding - Current
52.1M
Total Liabilities
88.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-19.786
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
32
Web
https://www.quincetx.com